stoxline Quote Chart Rank Option Currency Glossary
  
Covista Inc. (CVSA)
135.55  5.99 (4.62%)    07-07 16:00
Open: 131.64
High: 135.59
Volume: 458,931
  
Pre. Close: 129.56
Low: 129.44
Market Cap: 4,613(M)
Technical analysis
2026-07-07 4:43:32 PM
Short term     
Mid term     
Targets 6-month :  158.36 1-year :  184.97
Resists First :  135.58 Second :  158.36
Pivot price 123.87
Supports First :  122.97 Second :  115.18
MAs MA(5) :  129.57 MA(20) :  125.05
MA(100) :  115.06 MA(250) :  117.68
MACD MACD :  2.1 Signal :  1
%K %D K(14,3) :  88.1 D(3) :  79.1
RSI RSI(14): 66.9
52-week High :  156.25 Low :  86.97
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ CVSA ] has closed Bollinger Bands are 33.3% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 135.74 - 136.28 136.28 - 136.75
Low: 127.99 - 128.64 128.64 - 129.19
Close: 134.39 - 135.49 135.49 - 136.43
Company Description

Adtalem Global Education, Inc. is an enterprise dedicated to providing higher education. The company organizes its operations into three primary divisions: Chamberlain, Walden, and Medical and Veterinary. The Chamberlain segment delivers various degree and non-degree offerings within the nursing and broader health professions higher education sector. Through its Walden segment, the company offers extensive online learning options, including certificates, bachelor's, master's, and doctoral degrees in a wide range of subjects such as nursing, education, counseling, business, psychology, public health, social work, human services, public administration, public policy, and criminal justice. The Medical and Veterinary division provides both degree-granting and non-degree curricula tailored for post-secondary education in medicine and veterinary sciences. Dennis J. Keller and Ronald L. Taylor established the company in 1973, and its corporate headquarters are situated in Chicago, Illinois.

Headline News

Fri, 26 Jun 2026
Enterprise value to EBITDA forward of Covista Inc. – NYSE:CVSA - TradingView

Thu, 25 Jun 2026
Covista Inc. Actuals & Estimates (NYSE:CVSA) - TradingView

Thu, 25 Jun 2026
CVSA Forecast — Price Target — Prediction for 2027 - TradingView

Sun, 14 Jun 2026
Covista (CVSA) Stock Valuation Check After Recent Trading Volatility - Yahoo Finance

Fri, 12 Jun 2026
Insider Sell: Stephen Beard, Chairman & CEO of Covista Inc, Sells 5,291 Shares - GuruFocus

Thu, 11 Jun 2026
Guidance Hike Asserts Why Covista Inc. (CVSA) is One of the Best Defensive Stocks to Buy - Yahoo Finance

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Neutral
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Outperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Outperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
NYSE
Sector:
Consumer Cyclical
Industry:
Personal Products & Services
Shares Out 34 (M)
Shares Float 33 (M)
Held by Insiders 2.5 (%)
Held by Institutions 106.3 (%)
Shares Short 1,640 (K)
Shares Short P.Month 1,520 (K)
Stock Financials
EPS 6.86
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 40.09
Profit Margin 12.2 %
Operating Margin 18.9 %
Return on Assets (ttm) 8.3 %
Return on Equity (ttm) 17.8 %
Qtrly Rev. Growth 4.5 %
Gross Profit (p.s.) 32.03
Sales Per Share 56.12
EBITDA (p.s.) 12.48
Qtrly Earnings Growth -24.7 %
Operating Cash Flow 406 (M)
Levered Free Cash Flow 275 (M)
Stock Valuations
PE Ratio 19.73
PEG Ratio 0.8
Price to Book value 3.38
Price to Sales 2.41
Price to Cash Flow 11.35
Stock Dividends
Dividend 0.18
Forward Dividend 0
Dividend Yield 0.1%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android